Accelerate Sustainable Pharmaceutical Manufacturing with Exclusive On-Demand Learning Through ISPE Membership

How can pharmaceutical companies meet ambitious sustainability targets while maintaining compliance, product quality, and operational performance? What strategies are organizations using to reduce carbon emissions, optimize water and energy consumption, and build more sustainable facilities? And how are industry leaders navigating evolving regulations; environmental, social, and governance (ESG) expectations; and the transition to net-zero operations?

Sustainability has become one of the defining priorities for the pharmaceutical industry. Regulatory developments, investor expectations, resource constraints, and corporate environmental commitments are driving organizations to rethink how facilities are designed, operated, and optimized. From clean utilities and HVAC systems to digitalization, circular economy initiatives, and sustainable facility design, life sciences organizations are pursuing innovative approaches to reduce environmental impact while supporting business growth and patient access.

To help professionals stay ahead of these changes, ISPE is offering new and renewing members access to a curated collection of expert-led, on-demand conference sessions through the Sustainability learning pathway. Available with ISPE membership registration or renewal, these recordings provide practical implementation strategies, regulatory insights, case studies, and lessons learned from organizations advancing sustainability across the pharmaceutical sector.

Whether responsibilities include engineering, facilities management, manufacturing, quality, environmental health and safety (EHS), project management, utilities, sustainability leadership, or executive decision-making, this learning pathway provides valuable guidance for building more sustainable pharmaceutical operations.

Expert-Led Sustainability Sessions Available with ISPE Membership Registration or Renewal

• Digitalization and Sustainability: Path to Net-Zero: Digital transformation is becoming a powerful sustainability enabler.

  Rodrigo Alves, Manager, Sustainability and Energy Management, Rockwell Automation, demonstrates how connected data systems, digital technologies, and integrated processes can optimize energy consumption, reduce waste, improve operational efficiency, and support net-zero ambitions.

• Paving the Path: Our Continuing Journey to Sustainability Excellence: Kevin Conkright, Associate Director, Environmental and Sustainability Lead, AstraZeneca, shares the sustainability transformation of AstraZeneca’s Indiana manufacturing facility.

  The presentation explores how the site achieved near-zero Scope 1 and Scope 2 emissions while increasing production capacity, along with key lessons learned throughout the journey.

• Leveraging Competition to Drive Sustainability: Innovative engagement strategies can accelerate sustainability performance.

  Melanee Short, Head of Sustainability, Global Engineering, Sanofi, shares how Sanofi partnered with McLaren to create a competitive energy-efficiency program across major manufacturing sites. Learn how gamification, performance measurement, and knowledge sharing helped increase visibility and drive results.

• Sustainability Sterilization: Unavoidable Particles: As regulatory and supply-chain pressures affect single-use technologies, sustainability considerations are becoming increasingly important. Aidan Harrington, PhD, Principal Consultant, CQV and Regulatory Science, DPS Group Global, examines challenges related to PFAS restrictions, Cobalt-60 availability, and technically unavoidable particles. The session explores how collaboration among pharmaceutical manufacturers, suppliers, and regulators can support the continued and sustainable use of single-use systems.
   
• EU Chemicals Legislation Drives Industry to Sustainability: The regulatory landscape is changing rapidly across Europe. Mirella Miettinen, PhD, Academy Research Fellow in Environmental Law, University of Eastern Finland, presents an analysis of evolving EU chemicals legislation, including REACH amendments, PFAS restrictions, packaging requirements, emissions regulations, and sustainability reporting obligations. The session also examines how these developments are influencing pharmaceutical industry practices and green transformation initiatives.
   
• Transforming Pharmaceutical Plants for Enhanced Sustainability: How can pharmaceutical facilities reduce resource consumption without compromising operational performance? Alessandro Rosengart, PhD, SME Sustainability and Green Engineering, VTU Engineering, and Pierre-Emmanuel Cau, Head of Global Physical Asset Management and Real Estate, UCB, share real-world case studies demonstrating strategies for heat recovery, solvent recycling, water reuse, and carbon reduction. Attendees gain insight into balancing environmental improvements with economic and production objectives.
   
• Integration of Sustainability Objectives on Pharma Projects: Sustainability goals are increasingly becoming project requirements rather than optional considerations. Estelle Darnon, PhD, Head, Life Sciences Process Department, Technip Energies, explores how sustainability objectives can be embedded throughout pharmaceutical project lifecycles. Examples include building thermal studies, sustainable HVAC evaluations, energy-saving technologies, digital construction practices, and waste reduction initiatives.
   
• Aligning with Annex 1: Risk-Based Room Classifications and Sustainable Facility Design: Regulatory compliance and sustainability objectives can often complement one another. Gwendolyn Foster, Associate Director, Program Management, Lonza, presents a case study illustrating how Annex 1 guidance was applied within a large-scale biopharmaceutical facility to support risk-based cleanroom classification decisions. Learn how science-based approaches can deliver operational efficiencies while maintaining regulatory alignment.
   
• A More Sustainable and Annex 1 Compliant HVAC Design: HVAC systems frequently account for the majority of facility energy consumption. Alfred Penfold, Technical Director, GMP/Regulatory Compliance, PM Group, and Eilis Kelly, Senior Principal Scientist, Johnson & Johnson, discuss strategies for designing cleanroom HVAC systems that satisfy Annex 1 requirements while improving sustainability performance, reducing energy demand, and lowering operating costs.
   
• Real-Life Case Studies on Sustainability: Gain practical perspectives from industry experts as they discuss sustainability initiatives presented at the 2026 ISPE Europe Annual Conference. This interactive forum features Michael Keohane, Group Sustainability SME, PM Group; Brian McKnight, Group Technical Director, Building Services Engineering, PM Group; Dominik Hof, PE, Customer Application Engineer, OPTIMA Pharma GmbH; and Rodrigo Alves, Manager, Sustainability and Energy Management, Rockwell Automation. The discussion provides deeper insights into implementation challenges, outcomes, and lessons learned.
   
• Critical Utilities Sustainability: Case Study: Clean utility systems represent some of the largest consumers of energy and water in pharmaceutical facilities. Dino Valente, Regional Sales Manager, Stilmas Americas, presents a structured sustainability assessment methodology and a real-world case study demonstrating how advanced utility technologies can improve resource efficiency and support facility sustainability goals.
   
• Process Mass Intensity for Sustainable Biotech Decisions: Sustainability decisions increasingly require measurable benchmarks. Neil Gamble, Process Engineering Department Manager, Arcadis, introduces Process Mass Intensity (PMI) as a tool for evaluating resource consumption, carbon impact, and operational costs across biotechnology manufacturing systems. The presentation provides decision-makers with practical methods for comparing single-use and stainless-steel production approaches.
   
• Successful Business Cases for Sustainability Initiatives: One of the greatest barriers to sustainability projects is securing organizational support and funding. Christian Lavarreda, Director of Business Development, Syntegon, shares practical strategies for building persuasive business cases that connect environmental benefits with financial performance, risk management, regulatory readiness, and corporate strategy.
   
• LEED v5: Advancing ESG and Sustainability: The latest version of LEED places greater emphasis on carbon reduction, resilience, and ESG performance. Heather Walters, Director of Sustainable Design and Delivery, CRB Group, explains how pharmaceutical and biotechnology organizations can leverage LEED v5 to support sustainability commitments, enhance facility performance, and align with evolving stakeholder expectations.
   
• From Sustainability Goals to Governance: Case Studies for Enterprise and Facility-Level Engagement: Building a sustainability culture requires more than technology investments. Annie Kell, Sustainability Services Delivery Lead, Burns & McDonnell, and Joby Carlson, Head of Sustainability Operations, Zoetis, present practical examples of governance frameworks, environmental leadership programs, and site-level engagement strategies designed to drive continuous improvement across global operations.

Building a More Sustainable Future for Pharmaceutical Manufacturing

Collectively, these sessions demonstrate that sustainability is now a strategic business imperative for pharmaceutical manufacturers. From regulatory compliance and facility design to energy management, utilities optimization, digitalization, and governance, the Sustainability Learning Pathway highlights the practical approaches organizations are using to achieve meaningful environmental progress while maintaining quality, compliance, and operational excellence.

Participants gain exposure to proven implementation strategies, measurable sustainability frameworks, real-world case studies, and expert perspectives from some of the industry’s leading organizations. Equally important, these sessions illustrate how sustainability initiatives can create long-term value through operational efficiency, risk reduction, resilience, and innovation.

For professionals seeking to strengthen their sustainability expertise, support organizational ESG goals, and contribute to the future of pharmaceutical manufacturing, this exclusive on-demand content provides a valuable opportunity to learn directly from industry leaders advancing sustainability throughout the life sciences sector.

Use promo code ISPE26SUSTAIN to secure access to the recordings when joining or renewing an ISPE membership.

Offer expires Friday, 25 September 2026.

Learn about the three learning pathways available to choose from.

Join or renew today.

Restrictions apply.